22nd treatment shown to reduce risk in
May 2021, now with p = 0.00036 from 21 studies, recognized in 7 countries.
Efficacy is variant dependent.
No treatment is 100% effective. Protocols
combine treatments.
5,100+ studies for
112 treatments. c19early.org
|
risk of hospitalization or ER visit, 84.5% lower, RR 0.15, p = 0.049, treatment 112, control 156.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |